Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same authorSame Topic

Ischemic Postconditioning in Patients With Acute Stroke With Successful Recanalization After Endovascular Therapy: A Pilot Randomized Controlled Trial.

Stroke·2026
Same author

Visit-to-Visit Blood Pressure Variability and Cerebral White Matter Lesion Progression: A Pooled Individual Patient Data Analysis of 2 Trials.

Neurology·2026
Same author

Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial.

Stroke·2026
Same author

Blood Pressure Variability and Outcomes Across Antihypertensive Regimens.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

The translational potential of drug-induced hypothermia in acute ischemic stroke.

Science translational medicine·2026
Same author

Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke.

CNS neuroscience & therapeutics·2026

関連する実験動画

Updated: May 2, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

29.4K

急性不全性脳卒中におけるインサイト不全性コンディショニング:予備調査

Xiao Jiang1, Longfei Wu2, Shuling Liu3

  • 1Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin, China.

Journal of neurointerventional surgery
|September 1, 2025
PubMed
まとめ

脳卒中の血栓切除術後の不血性コンディショニング (IPostC) は,深い心臓発作の容量を減少させ,免疫反応を調節する可能性があります. 急性不全性脳卒中患者の神経保護効果を確認するには,さらなる試験が必要である.

キーワード:
介入再注入する脳卒中トロンベクトミー

さらに関連する動画

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.5K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K

関連する実験動画

Last Updated: May 2, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

29.4K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.5K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K

科学分野:

  • 神経科学
  • 心血管医学
  • 免疫学

背景:

  • 血管内治療は急性不全性脳卒中に対して有効ですが,結果は異なります.
  • 臨床前モデルでは潜在的神経保護が示されているが,ヒトに関するデータは欠けている.
  • この研究では,機械的血栓切除術後の心臓発作量に対するIPostCの効果を in situで調査した.

研究 の 目的:

  • メカニカル・トロンベクトミーを受けた急性不全性脳卒中患者の心臓発作量に対するインシット・イシュケミック・ポストコンディショニング (IPostC) の影響を評価する.
  • 白血球集団と炎症バイオマーカーを分析することによって,IPostCの免疫調節効果を評価する.

主な方法:

  • IPostC + 血栓切除と血栓切除のみを比較する前向きな,外部制御された,ランダム化されていない試験.
  • 偏差を最小限に抑えるために,プロペンス・スコア・マッチング (PSM) を用いて,グループごとに19人の患者を分析した.
  • 主要評価は72時間後の心臓発作量で,次要評価は深部心臓発作量,白血球サブセット,血清炎症マーカーでした.

主要な成果:

  • IPostC群では,深い心臓発作の体積の進行が著しく減少した (2. 3 vs 4. 7 mL).
  • IPostCはインタールイキン-6濃度 (26. 4 vs 32. 6 pg/ mL) と自然キラー細胞の割合の減少 (1. 10% vs 1. 68%) と関連付けられました.
  • 高いTh/ CTL比 (2. 04対1. 65) がIPostC群で観察されました.

結論:

  • 大きな血管の閉塞性脳卒中のメカニカル・トロンベクトミー後のIPostCは,深い心臓発作の体積の進行を減少させる可能性があります.
  • IPostCは,炎症の減少とT細胞/NK細胞バランスの変化を含む,好ましい免疫調節効果があるようです.
  • IPostCの有効性と安全性を確認するために,第2相試験でのさらなる検証が必要である.